US12122795B2 - Preparation of N∧N∧C∧N tetradentate platinum (II) complex and uses thereof - Google Patents
Preparation of N∧N∧C∧N tetradentate platinum (II) complex and uses thereof Download PDFInfo
- Publication number
- US12122795B2 US12122795B2 US17/297,998 US201917297998A US12122795B2 US 12122795 B2 US12122795 B2 US 12122795B2 US 201917297998 A US201917297998 A US 201917297998A US 12122795 B2 US12122795 B2 US 12122795B2
- Authority
- US
- United States
- Prior art keywords
- group
- circumflex over
- complex
- carbon atoms
- mmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- HRGDZIGMBDGFTC-UHFFFAOYSA-N platinum(2+) Chemical compound [Pt+2] HRGDZIGMBDGFTC-UHFFFAOYSA-N 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title abstract description 5
- 239000000463 material Substances 0.000 claims abstract description 16
- 125000004432 carbon atom Chemical group C* 0.000 claims description 38
- 125000000217 alkyl group Chemical group 0.000 claims description 33
- 125000003118 aryl group Chemical group 0.000 claims description 29
- 239000003446 ligand Substances 0.000 claims description 14
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 12
- 229910052739 hydrogen Inorganic materials 0.000 claims description 11
- 239000001257 hydrogen Substances 0.000 claims description 11
- 230000000694 effects Effects 0.000 claims description 4
- 239000002243 precursor Substances 0.000 claims description 3
- 238000002207 thermal evaporation Methods 0.000 claims description 3
- 238000007641 inkjet printing Methods 0.000 claims description 2
- 238000004528 spin coating Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 238000005401 electroluminescence Methods 0.000 abstract description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 102
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 34
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 28
- 229910001873 dinitrogen Inorganic materials 0.000 description 28
- 238000006243 chemical reaction Methods 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 24
- 239000002904 solvent Substances 0.000 description 23
- 229910052736 halogen Inorganic materials 0.000 description 22
- 150000002367 halogens Chemical group 0.000 description 22
- 238000002390 rotary evaporation Methods 0.000 description 22
- 150000001875 compounds Chemical class 0.000 description 21
- 230000015572 biosynthetic process Effects 0.000 description 20
- 238000003786 synthesis reaction Methods 0.000 description 19
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 17
- 238000004440 column chromatography Methods 0.000 description 17
- 238000001035 drying Methods 0.000 description 17
- 238000000605 extraction Methods 0.000 description 17
- 239000012074 organic phase Substances 0.000 description 17
- 239000007787 solid Substances 0.000 description 17
- 238000001816 cooling Methods 0.000 description 16
- 238000010438 heat treatment Methods 0.000 description 16
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 16
- 238000005086 pumping Methods 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- 125000001072 heteroaryl group Chemical group 0.000 description 13
- NFHFRUOZVGFOOS-UHFFFAOYSA-N Pd(PPh3)4 Substances [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 229910052731 fluorine Inorganic materials 0.000 description 9
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 8
- 239000000460 chlorine Substances 0.000 description 8
- 229910052801 chlorine Inorganic materials 0.000 description 8
- 238000001819 mass spectrum Methods 0.000 description 8
- 229910000027 potassium carbonate Inorganic materials 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 125000001424 substituent group Chemical group 0.000 description 8
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 229910052794 bromium Inorganic materials 0.000 description 6
- 125000005266 diarylamine group Chemical group 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 5
- 238000010791 quenching Methods 0.000 description 5
- 230000000171 quenching effect Effects 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 5
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 4
- 125000002252 acyl group Chemical group 0.000 description 4
- 125000003342 alkenyl group Chemical group 0.000 description 4
- 125000003545 alkoxy group Chemical group 0.000 description 4
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 4
- 229940126214 compound 3 Drugs 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 125000004093 cyano group Chemical group *C#N 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 239000013212 metal-organic material Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 4
- 238000002061 vacuum sublimation Methods 0.000 description 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 3
- XSCHRSMBECNVNS-UHFFFAOYSA-N benzopyrazine Natural products N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 229910052741 iridium Inorganic materials 0.000 description 3
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 description 3
- -1 nitrogenous heterocyclic compounds Chemical class 0.000 description 3
- 125000005245 nitryl group Chemical group [N+](=O)([O-])* 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 125000004417 unsaturated alkyl group Chemical group 0.000 description 3
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 2
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 2
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 2
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 2
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 2
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 2
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 2
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 2
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 2
- AWXGSYPUMWKTBR-UHFFFAOYSA-N 4-carbazol-9-yl-n,n-bis(4-carbazol-9-ylphenyl)aniline Chemical compound C12=CC=CC=C2C2=CC=CC=C2N1C1=CC=C(N(C=2C=CC(=CC=2)N2C3=CC=CC=C3C3=CC=CC=C32)C=2C=CC(=CC=2)N2C3=CC=CC=C3C3=CC=CC=C32)C=C1 AWXGSYPUMWKTBR-UHFFFAOYSA-N 0.000 description 2
- ZOKIJILZFXPFTO-UHFFFAOYSA-N 4-methyl-n-[4-[1-[4-(4-methyl-n-(4-methylphenyl)anilino)phenyl]cyclohexyl]phenyl]-n-(4-methylphenyl)aniline Chemical compound C1=CC(C)=CC=C1N(C=1C=CC(=CC=1)C1(CCCCC1)C=1C=CC(=CC=1)N(C=1C=CC(C)=CC=1)C=1C=CC(C)=CC=1)C1=CC=C(C)C=C1 ZOKIJILZFXPFTO-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- OJRUSAPKCPIVBY-KQYNXXCUSA-N C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)O)O)O)O)I)N Chemical compound C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)O)O)O)O)I)N OJRUSAPKCPIVBY-KQYNXXCUSA-N 0.000 description 2
- 229940126657 Compound 17 Drugs 0.000 description 2
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical group [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- 101000837344 Homo sapiens T-cell leukemia translocation-altered gene protein Proteins 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 238000006069 Suzuki reaction reaction Methods 0.000 description 2
- 102100028692 T-cell leukemia translocation-altered gene protein Human genes 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 125000004062 acenaphthenyl group Chemical group C1(CC2=CC=CC3=CC=CC1=C23)* 0.000 description 2
- 125000004442 acylamino group Chemical group 0.000 description 2
- 125000004423 acyloxy group Chemical group 0.000 description 2
- 125000004104 aryloxy group Chemical group 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 229940125797 compound 12 Drugs 0.000 description 2
- 229940125758 compound 15 Drugs 0.000 description 2
- 229940126142 compound 16 Drugs 0.000 description 2
- 229940125810 compound 20 Drugs 0.000 description 2
- 229940126086 compound 21 Drugs 0.000 description 2
- 229940125898 compound 5 Drugs 0.000 description 2
- 229910052805 deuterium Inorganic materials 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000002019 doping agent Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 150000003222 pyridines Chemical class 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 125000005504 styryl group Chemical group 0.000 description 2
- 239000011593 sulfur Chemical group 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- UGUHFDPGDQDVGX-UHFFFAOYSA-N 1,2,3-thiadiazole Chemical compound C1=CSN=N1 UGUHFDPGDQDVGX-UHFFFAOYSA-N 0.000 description 1
- YGTAZGSLCXNBQL-UHFFFAOYSA-N 1,2,4-thiadiazole Chemical compound C=1N=CSN=1 YGTAZGSLCXNBQL-UHFFFAOYSA-N 0.000 description 1
- KTZQTRPPVKQPFO-UHFFFAOYSA-N 1,2-benzoxazole Chemical compound C1=CC=C2C=NOC2=C1 KTZQTRPPVKQPFO-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- BMIBJCFFZPYJHF-UHFFFAOYSA-N 2-methoxy-5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine Chemical class COC1=NC=C(C)C=C1B1OC(C)(C)C(C)(C)O1 BMIBJCFFZPYJHF-UHFFFAOYSA-N 0.000 description 1
- GDRVFDDBLLKWRI-UHFFFAOYSA-N 4H-quinolizine Chemical compound C1=CC=CN2CC=CC=C21 GDRVFDDBLLKWRI-UHFFFAOYSA-N 0.000 description 1
- MAAHYFVFZLWJDN-UHFFFAOYSA-N 9H-carbazole 1H-pyrazole Chemical class C1=CC=CC=2C3=CC=CC=C3NC12.N1N=CC=C1 MAAHYFVFZLWJDN-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 101000687716 Drosophila melanogaster SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 homolog Proteins 0.000 description 1
- 229910052693 Europium Inorganic materials 0.000 description 1
- 229910020427 K2PtCl4 Inorganic materials 0.000 description 1
- 101000687741 Mus musculus SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 Proteins 0.000 description 1
- NUGPIZCTELGDOS-QHCPKHFHSA-N N-[(1S)-3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-pyridin-3-ylpropyl]cyclopentanecarboxamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CC[C@@H](C=1C=NC=CC=1)NC(=O)C1CCCC1)C NUGPIZCTELGDOS-QHCPKHFHSA-N 0.000 description 1
- LFZAGIJXANFPFN-UHFFFAOYSA-N N-[3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-thiophen-2-ylpropyl]acetamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CCC(C=1SC=CC=1)NC(C)=O)C LFZAGIJXANFPFN-UHFFFAOYSA-N 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 238000006619 Stille reaction Methods 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
- NABLVPQEFBPJDZ-UHFFFAOYSA-N [Sn].[In].[Sn] Chemical compound [Sn].[In].[Sn] NABLVPQEFBPJDZ-UHFFFAOYSA-N 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000006620 amino-(C1-C6) alkyl group Chemical group 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 150000001716 carbazoles Chemical class 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 150000004696 coordination complex Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical group C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 150000002240 furans Chemical class 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 230000005525 hole transport Effects 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 125000001828 phenalenyl group Chemical group C1(C=CC2=CC=CC3=CC=CC1=C23)* 0.000 description 1
- 230000021715 photosynthesis, light harvesting Effects 0.000 description 1
- LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical compound C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- CPNGPNLZQNNVQM-UHFFFAOYSA-N pteridine Chemical compound N1=CN=CC2=NC=CN=C21 CPNGPNLZQNNVQM-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229940079827 sodium hydrogen sulfite Drugs 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01K—ELECTRIC INCANDESCENT LAMPS
- H01K5/00—Lamps for general lighting
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K71/00—Manufacture or treatment specially adapted for the organic devices covered by this subclass
- H10K71/10—Deposition of organic active material
- H10K71/12—Deposition of organic active material using liquid deposition, e.g. spin coating
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/30—Coordination compounds
- H10K85/341—Transition metal complexes, e.g. Ru(II)polypyridine complexes
- H10K85/346—Transition metal complexes, e.g. Ru(II)polypyridine complexes comprising platinum
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/18—Metal complexes
- C09K2211/185—Metal complexes of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K2101/00—Properties of the organic materials covered by group H10K85/00
- H10K2101/10—Triplet emission
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
- H10K50/12—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers comprising dopants
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K71/00—Manufacture or treatment specially adapted for the organic devices covered by this subclass
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K71/00—Manufacture or treatment specially adapted for the organic devices covered by this subclass
- H10K71/40—Thermal treatment, e.g. annealing in the presence of a solvent vapour
Definitions
- the present invention relates to a novel N ⁇ circumflex over ( ) ⁇ N ⁇ circumflex over ( ) ⁇ C ⁇ circumflex over ( ) ⁇ N tetradentate platinum (II) complex metal organic material, and more particularly relates to a phosphorescent doped material achieving a photon emission effect in a light-emitting layer of an OLED light-emitting device.
- OLEDs Organic Light-Emitting Diodes
- the development of a phosphorescent OLED light-emitting layer doped material is fast and mature. It is mainly based on some heavy metal organic complexes, such as iridium, platinum, europium and osmium.
- the phosphorescent material can sufficiently utilize singlet and triplet exciton energy in the light-emitting process, so that its quantum efficiency can theoretically reach 100%. Therefore, the phosphorescent material is a light-emitting material with wider application in the industry at present.
- platinum (II)-based phosphorescent OLED material has gradually developed and achieved good research achievements.
- the platinum (II) is tetradentate, so that a complex of a plane structure is generally formed, and its ligands mainly include bidentate ligands, tridentate ligands and tetradentate ligands.
- the tetradentate ligands Compared with bidentate or tridentate ligands, the tetradentate ligands have the following advantages:
- a platinum (II) complex can be synthesized through one-step reaction of the ligands, so that the preparation and purification of the platinum (II) complex are easy.
- the tetradentate ligand platinum (II) complexes have attracted much research and attention because of their unique performance. Especially, the subject group of academicians of Zhi Zhiming studied this kind of complexes deeply and achieved excellent achievements.
- Zhi Zhiming et al. first reported Pt(O ⁇ circumflex over ( ) ⁇ N ⁇ circumflex over ( ) ⁇ N ⁇ circumflex over ( ) ⁇ O) type complexes as shown in Formula (1).
- Zhi Zhiming et al. reported a series of Pt(O ⁇ circumflex over ( ) ⁇ N ⁇ circumflex over ( ) ⁇ N ⁇ circumflex over ( ) ⁇ O) complexes based on Schiff bases.
- Li et al. reported a series of pyrazole-carbazole-based Pt(II) complexes which have excellent performance, extremely high efficiency and low roll-off effects, as shown in Formulas (4) to (10), and the external quantum efficiency of a green-light OLED based on Formula (4) is as high as 25.6%.
- the tetradentate ligand platinum (II) complex shows good performance.
- the molecules of the platinum (II) complex are easy to stack, and easy to form excimers and the like, influencing the performance of an OLED device.
- a large-steric-hindrance group such as a tert-butyl group is generally added to the molecule, so that a three-dimensional structure of the molecule is enhanced, and the interaction among the molecules is weakened.
- OLED display technology is a difficult and significant research, it has good characteristics and also has the disadvantages of short service life, poor color purity, easy aging and the like, and these disadvantages limits the large-scale application of the OLED technology. Therefore, designing a novel OLED material with excellent performance, especially a light-emitting layer doped material is the focus and difficulty of the research in the field of OLED.
- the present invention designs a novel Pt (II) complex with a N ⁇ circumflex over ( ) ⁇ N ⁇ circumflex over ( ) ⁇ C ⁇ circumflex over ( ) ⁇ N coordination structure based on a carbazole framework, and studies application of the novel Pt (II) complex to OLEDs.
- Carbazole is a class of electron-rich nitrogenous heterocyclic compounds having a big ⁇ -conjugate rigid plane structure, and through such a unique structure, its derivative shows various kinds of excellent photoelectric performance.
- a novel N ⁇ circumflex over ( ) ⁇ N ⁇ circumflex over ( ) ⁇ C ⁇ circumflex over ( ) ⁇ N tetradentate platinum (II) complex metal organic material of the present invention has a structure as shown in the following formula:
- R 1 to R 16 are independently selected from hydrogen, deuterium, sulfur, halogen, a hydroxyl group, an acyl group, an alkoxy group, an acyloxy group, an amino group, a nitryl group, an acylamino group, a cyano group, a carboxyl group, a styryl group, an aminocarbonyl group, a carbamoyl group, a benzylcarbonyl group, an aryloxy group, a diarylamine group, a saturated alkyl group containing 1 to 30 carbon atoms, an unsaturated alkyl group containing 1 to 20 carbon atoms, a substituted or unsubstituted aryl group containing 5 to 30 carbon atoms, or a substituted or unsubstituted heteroaryl group containing 5 to 30 carbon atoms, or adjacent R 1 to R 16 are connected to each other by a covalent bond to form a ring.
- R 1 to R 16 are independently selected from hydrogen, halogen, an amino group, a nitryl group, a cyano group, a diarylamine group, a saturated alkyl group containing 1 to 10 carbon atoms, an aryl group containing 5 to 20 carbon atoms and unsubstituted or substituted by halogen or one or more C1 to C4 alkyl groups, or a heteroaryl group containing 5 to 20 carbon atoms and unsubstituted or substituted by halogen or one or more C1 to C4 alkyl groups, or adjacent R 1 to R 16 are connected to each other by a covalent bond to form a ring, wherein the halogen is F, Cl or Br
- R 1 ′ to R 5 ′ are independently selected from hydrogen, halogen, a diarylamine group, a saturated alkyl group containing 1 to 10 carbon atoms, an aryl group containing 5 to 20 carbon atoms and unsubstituted or substituted by halogen or one or more C1 to C4 alkyl groups, or a heteroaryl group containing 5 to 20 carbon atoms and unsubstituted or substituted by halogen or one or more C1 to C4 alkyl groups, or adjacent R 1 ′ to R 5 ′ are connected to each other by a covalent bond to form a ring, wherein the halogen is F, Cl or Br.
- 0 to 3 of the 5 groups of R 1 ′ to R 5 ′ are independently represented as a diarylamine group, an aryl group containing 5 to 10 carbon atoms and unsubstituted or substituted by halogen or 1 to 3 C1 to C4 alkyl groups, or a heteroaryl group containing 5 to 10 carbon atoms and unsubstituted or substituted by halogen or 1 to 3 C1 to C4 alkyl groups; and other groups are independently represented as hydrogen, halogen or a saturated alkyl group containing 1 to 8 carbon atoms, wherein the halogen is F or Cl.
- 0 to 3 of the 5 groups of R 1 ′ to R 5 ′ are independently represented as a diphenylamine group, a phenyl group unsubstituted or substituted by C1 to C4 alkyl groups, a pyridyl group or a carbazolyl group, and other groups are independently represented as hydrogen, fluorine or a saturated alkyl group containing 1 to 4 carbon atoms.
- a precursor, i.e., a ligand, of the above compound has a structural formula as shown in Formula (12):
- R 1 to R 16 are independently selected from hydrogen, deuterium, sulfur, halogen, a hydroxyl group, an acyl group, an alkoxy group, an acyloxy group, an amino group, a nitryl group, an acylamino group, a cyano group, a carboxyl group, a styryl group, an aminocarbonyl group, a carbamoyl group, a benzylcarbonyl group, an aryloxy group, a diarylamine group, a saturated alkyl group containing 1 to 30 carbon atoms, an unsaturated alkyl group containing 1 to 20 carbon atoms, a substituted or unsubstituted aryl group containing 5 to 30 carbon atoms, or a substituted or unsubstituted heteroaryl group containing 5 to 30 carbon atoms, or adjacent R 1 to R 16 are connected to each other by a covalent bond to form a ring.
- the precursor has a structural formula as follows:
- R 1 ′ to R 5 ′ are independently selected from hydrogen, halogen, a diarylamine group, a saturated alkyl group containing 1 to 10 carbon atoms, an aryl group containing 5 to 20 carbon atoms and unsubstituted or substituted by halogen or one or more C1 to C4 alkyl groups, or a heteroaryl group containing 5 to 20 carbon atoms and unsubstituted or substituted by halogen or one or more C1 to C4 alkyl groups, or adjacent R 1 ′ to R 5 ′ are connected to each other by a covalent bond to form a ring, wherein the halogen is F, Cl or Br.
- halogen alkyl group, alkenyl group, aryl group, acyl group, alkoxy group and heterocyclic aromatic system or heterocyclic aromatic group may have the following meanings:
- halogen or halogenation includes fluorine, chlorine, bromine and iodine, preferably F, Cl or Br, more preferably F or Cl, and most preferably F.
- the aryl group or the heteroaryl group includes an aryl group containing 5 to 30 carbon atoms, preferably 5 to 20 carbon atoms, more preferably 5 to 10 carbon atoms and consisting of one aromatic ring or a plurality of condensed aromatic rings.
- a suitable aryl group for example, is a phenyl group, a naphthyl group, an acenaphthenyl group, an acenaphthenyl group, an anthracenyl group, a fluorenyl group, or a phenalenyl group.
- the aryl group may be unsubstituted (i.e., all carbon atoms capable of being substituted carry hydrogen atoms) or substituted at one, more than one, or all substitutable positions of the aryl group.
- a suitable substituent group is, for example, halogen, preferably F, Br or Cl; an alkyl group, preferably an alkyl group containing 1 to 20, 1 to 10 or 1 to 8 carbon atoms, and particularly preferably a methyl group, an ethyl group, an isopropyl group or a tert-butyl group; an aryl group, preferably a re-substitutable or unsubstituted C 5 , C 6 aryl group or fluorenyl group; a heteroaryl group, preferably a heteroaryl group containing at least one nitrogen atom, and particularly preferably a pyridyl group; an aryl group, particularly preferably carrying a substituent group selected from F and a tert-
- the unsaturated alkyl group containing 1 to 20 carbon atoms is preferably an alkenyl group, more preferably an alkenyl group with a double bond, and particularly preferably an alkenyl group with a double bond and 1 to 8 carbon atoms.
- the alkyl group includes an alkyl group containing 1 to 30 carbon atoms, preferably 1 to 10 carbon atoms, and more preferably 1 to 4 carbon atoms.
- the alkyl group may be branched or linear, or cyclic, and may be interrupted by one or more heteroatoms, preferably by N, O, or S.
- the alkyl group may be substituted by one or more halogens or the above substituent groups relevant to the aryl group.
- the alkyl group it is possible to carry one or more aryl groups, all of the above aryl groups are suitable for this purpose, and the alkyl group is particularly preferably selected from a methyl group, an ethyl group, an isopropyl group, an n-propyl group, an isobutyl group, a n-butyl group, a tert-butyl group, a sec-butyl group, an isopentyl group, a cyclopropyl group, a cyclopentyl group, and a cyclohexyl group.
- the acyl group is connected to a CO group by a single bond, such as the alkyl group used herein.
- the alkoxy group is directly connected to oxygen by a single bond, such as the alkyl group used herein.
- the heteroaryl group is understood to be related to an aromatic, C 3 -C 8 ring group, and also contains an oxygen or sulfur atom or 1-4 nitrogen atoms or a combination of an oxygen or sulfur atom and at most two nitrogen atoms, and their substituted and benzo and pyrido fused derivatives, for example, through connection by one of ring-forming carbon atoms, the heteroaryl group may be substituted by one or more of the substituent groups relevant to the aryl group.
- the heteroaryl group may be a five-membered or six-membered aromatic heterocyclic ring system carrying the independent groups containing 0, 1, or 2 substituent groups.
- a typical example of the heteroaryl group includes, but is not limited to unsubstituted furan, benzofuran, thiophene, benzothiophene, pyrrole, pyridine, indole, azole, benzoxazole, isoxazole, benzoisoxazole, thiazole, benzothiazole, isothiazole, imidazole, benzimidazole, pyrazole, indazole, tetrazole, quinoline, isoquinoline, pyridazine, pyrimidine, purine and pyrazine, furan, 1,2,3-diazole, 1,2,3-thiadiazole, 1,2,4-thiadiazole, triazole, benzotriazole, pteridine, benzoxazole, p
- the substituent group is a halogeno group, a hydroxyl group, a cyano group, a O—C 1-6 alkyl group, a C 1-6 alkyl group, a hydroxyl C 1-6 alkyl group, and an amino-C 1-6 alkyl group.
- An organic light-emitting device containing one or more of the above complexes is included.
- the complex is applied in a layer form in the device through thermal deposition.
- the complex is applied in a layer form in the device through spin coating.
- the complex is applied in a layer form in the device through inkjet printing.
- the organic light-emitting device emits orange-red light when current is applied.
- the organic metal complex in the present invention has the advantages high fluorescence quantum efficiency, high thermal stability and low quenching constant, and can be used to manufacture orange-red light OLED devices with high luminous efficiency and low roll-off.
- FIG. 1 is a schematic structure diagram of an organic electroluminescence device of the present invention.
- a preparation method of the complex includes the following steps:
- a carbazole derivative S1 takes a bromination reaction to obtain a substrate S2.
- the S2 takes a reaction with bis(pinacolato)diboron to obtain a corresponding pinacol ester derivative S3.
- the S3 takes a Suzuki reaction with a pyridine derivative S6 to obtain S7.
- the S7 takes a Suzuki reaction with a pyridine derivative S8 to obtain S9.
- the S9 takes a reaction with K 2 PtCl 4 to obtain a target product P.
- the S6 is prepared from the S4 and the S5 through a Stille reaction.
- Synthesis of Compound 2 11.2 g (40.0 mmol) of Compound 1 was taken, and dissolved in 600 mL of acetic acid. Then, 16.0 g (2.5 eq., 100.0 mmol) of liquid bromine was dripped in for light shading reaction. After stirring at a room temperature for about 4 hr, rotary evaporation was performed to remove a solvent. Next, a proper amount of water and sodium hydrogen sulfite solution were added for washing, extraction was performed by using ethyl acetate, and an organic phase was collected. After drying by using anhydrous magnesium sulfate, a proper amount of silica gel was added. Rotary evaporation was performed to remove a solvent.
- Synthetic routes of P2 are basically identical to those of P1. Synthesis of partial compounds was shown as follows:
- Synthetic routes of P3 are basically identical to those of P1. Synthesis of partial compounds was shown as follows:
- the Pt (II) complex according to the embodiment showed obvious orange red light emission in a dichloromethane solution, and a wavelength range was between 617 nm and 619 nm, as shown in the following table.
- a transparent anodized tin indium tin (ITO, 20) (10 ⁇ /sq) glass substrate 10 was ultrasonically cleaned by using acetone, ethanol and distilled water in sequence, and was then subjected to plasma treatment for 5 minutes by using oxygen gas.
- the ITO substrate was mounted on a substrate holder of vacuum vapor deposition equipment.
- a system pressure was controlled at 10-6 torr.
- a hole transport layer (30) material TAPC with a thickness of 60 nm was evaporated onto the ITO substrate.
- a light-emitting layer material (40) TCTA with a thickness of 40 nm was evaporated, and platinum (II) complex dopants in different mass percentage were doped.
- an electron transport layer (50) material TmPyPb with a thickness of 30 nm was evaporated.
- LiF with a thickness of 1 nm was evaporated as an electron injection layer (60).
- Pt0 is a classic O ⁇ circumflex over ( ) ⁇ N ⁇ circumflex over ( ) ⁇ N ⁇ circumflex over ( ) ⁇ O type red light material.
- the device was prepared by using the above ITO/HTL-1 (60 nm)/EML-1:Pt(II)(40 nm)/ETL-1 (30 nm)/LiF(1 nm)/Al(80 nm) device basic structure.
- start-up voltages V on of the devices of the tetradentate platinum (II) complexes P1, P2, P3 and P4 were reduced to different degrees through being compared to that of the device of P0.
- the current efficiency (CE), power efficiency (PE) and external quantum efficiency (EQE) of devices based on P1, P2, P3 and P4 were improved to different degrees through being compared to those of the device based on P0.
- the improvement of P4 in the current efficiency (CE), power efficiency (PE) and external quantum efficiency (EQE) was obvious.
- the doping concentration of the tetradentate platinum (II) complex was increased, the efficiency of P0 was slightly improved or even decreased to a certain degree. Because of a strong planar structure of P0, the interaction among molecules was increased, and the luminous efficiency was reduced.
- P1, P2, P3 and P4 had larger steric hindrance groups than P0, so that the aggregation effect among molecules could be effectively reduced, the formation of an exciplex could be avoided, and the luminous efficiency could be improved.
- the tetradentate platinum (II) complex according to the present invention has a ligand skeleton with a porphyrin-like structure, and a ligand central cavity can form strong chelate coordination with platinum (II), so it is beneficial to improve the complex stability, and beneficial to build long-life OLED devices.
- the ligand skeleton has an excellent rigid structure, the non-radiative energy dissipation such as intramolecular rotation and vibration can be greatly reduced, and the luminous efficiency and performance improvement of the platinum (II) complex is facilitated.
- the performance of an organic electroluminescence device prepared by the present invention is better than that of a reference device, and the related novel N ⁇ circumflex over ( ) ⁇ N ⁇ circumflex over ( ) ⁇ C ⁇ circumflex over ( ) ⁇ N tetradentate platinum (II) complex metal organic material has greater application values.
- the N ⁇ circumflex over ( ) ⁇ N ⁇ circumflex over ( ) ⁇ C ⁇ circumflex over ( ) ⁇ N tetradentate platinum (II) complex metal organic material prepared by the present invention has great application values to organic light-emitting diodes, and can be used as a phosphorescent doped material to manufacture an orange red light OLED device with a high
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Manufacturing & Machinery (AREA)
- Electroluminescent Light Sources (AREA)
Abstract
Description
The present invention will be further illustrated in detail in conjunction with Embodiments hereafter.
Synthesis of Compound 2: 11.2 g (40.0 mmol) of Compound 1 was taken, and dissolved in 600 mL of acetic acid. Then, 16.0 g (2.5 eq., 100.0 mmol) of liquid bromine was dripped in for light shading reaction. After stirring at a room temperature for about 4 hr, rotary evaporation was performed to remove a solvent. Next, a proper amount of water and sodium hydrogen sulfite solution were added for washing, extraction was performed by using ethyl acetate, and an organic phase was collected. After drying by using anhydrous magnesium sulfate, a proper amount of silica gel was added. Rotary evaporation was performed to remove a solvent. A n-hexane/ethyl acetate system was used for column chromatography, to obtain 15.7 g of white solids, the yield was 90%, and the purity was 99.9%.
Synthesis of Compound 6: 14.7 g (40.0 mmol) of Compound 5, 34.0 g of Compound 4 (3 eq., 120.0 mmol), and 924 mg of Pd(PPh3)4 (0.02 eq., 0.8 mmol) were taken, and added into a three-necked flask. Vacuum pumping was performed, and nitrogen gas was introduced for replacement for many times. Then, 200 mL of toluene was injected, and heating was performed to reach 105° C. After reaction for 12 hr under nitrogen gas protection, cooling was performed to reach the room temperature. A KF solution was used for quenching reaction. Then, a proper amount of water and ethyl acetate were added for extraction, and an organic phase was collected. After drying by using anhydrous magnesium sulfate, rotary evaporation was performed to remove a solvent. A n-hexane/ethyl acetate system was used for column chromatography, to obtain 7.5 g of white solids, the yield was 80%, and the purity was 99.5%.
Synthesis of Compound 7: 10.3 g (20.0 mmol) of Compound 3, 4.7 g (20.0 mmol) of Compound 6, 3.4 g of potassium carbonate (1.25 eq., 25 mmol) and 462 mg of Pd(PPh3)4 (0.02 eq., 0.4 mmol) were taken, and added into a three-necked flask. Vacuum pumping was performed, and nitrogen gas was introduced for replacement for many times. Then, 60 mL of dioxane and 20 mL of water were injected, and heating was performed to reach 100° C. After reaction for 12 hr under nitrogen gas protection, cooling was performed to reach the room temperature. Then, a proper amount of water and ethyl acetate were added for extraction, and an organic phase was collected. After drying by using anhydrous magnesium sulfate, rotary evaporation was performed to remove a solvent. A n-hexane/ethyl acetate system was used for column chromatography, to obtain 7.8 g of white solids, the yield was 70%, and the purity was 99.5%.
Synthesis of Compound 9: 5.6 g (10.0 mmol) of Compound 7, 1.9 g of Compound 8 (1.2 eq., 12.0 mmol), 1.7 g of potassium carbonate (1.25 eq., 12.5 mmol) and 230 mg of Pd(PPh3)4 (0.02 eq., 0.2 mmol) were taken, and added into a three-necked flask. Vacuum pumping was performed, and nitrogen gas was introduced for replacement for many times. Then, 30 mL of dioxane and 10 mL of water were injected, and heating was performed to reach 100° C. After reaction for 12 hr under nitrogen gas protection, cooling was performed to reach the room temperature. Then, a proper amount of water and ethyl acetate were added for extraction, and an organic phase was collected. After drying by using anhydrous magnesium sulfate, rotary evaporation was performed to remove a solvent. A n-hexane/ethyl acetate system was used for column chromatography, to obtain 4.6 g of white solids, the yield was 90%, and the purity was 99.9%. Mass spectrum: (ESI−) ([M-H]−). C36H35N3 theoretical value: 508.28. Measured value: 508.25.
Synthesis of Compound P1: 1.02 g (2.0 mmol) of Compound 9, 160 mg of tetrabutylammonium bromide (0.25 eq., 0.5 mmol) and 930 mg of potassium chloroplatinate (1.2 eq., 2.4 mmol) were taken, and dissolved in 25 mL of acetic acid. Vacuum pumping was performed, and nitrogen gas was introduced for replacement for many times. Heating was performed under stirring to reach 130° C. for reaction for 12 Hr. After the reaction was completed, cooling and rotary evaporation were performed to remove a solvent. Then, a proper amount of water and ethyl acetate were added for extraction, and an organic phase was collected. After drying by using anhydrous magnesium sulfate, rotary evaporation was performed to remove a solvent. A n-hexane/ethyl acetate system was used for column chromatography. An obtained crude product was subjected to vacuum sublimation to obtain 842 mg of dark red solids, the total yield was 60%, and the purity was 99.9%. Mass spectrum: (ESI−) ([M-H]−). C36H32N3Pt theoretical value: 508.28. Measured value: 508.25.
Synthetic routes of P2 are basically identical to those of P1. Synthesis of partial compounds was shown as follows:
Synthesis of Compound 11: 15.3 g (40.0 mmol) of
Synthesis of Compound 12: 10.3 g (20.0 mmol) of Compound 3, 5.0 g (20.0 mmol) of Compound 11, 3.4 g of potassium carbonate (1.25 eq., 25 mmol) and 462 mg of Pd(PPh3)4 (0.02 eq., 0.4 mmol) were taken, and added into a three-necked flask. Vacuum pumping was performed, and nitrogen gas was introduced for replacement for many times. Then, 60 mL of dioxane and 20 mL of water were injected, and heating was performed to reach 100° C. After reaction for 12 hr under nitrogen gas protection, cooling was performed to reach the room temperature. Then, a proper amount of water and ethyl acetate were added for extraction, and an organic phase was collected. After drying by using anhydrous magnesium sulfate, rotary evaporation was performed to remove a solvent. A n-hexane/ethyl acetate system was used for column chromatography, to obtain 7.8 g of white solids, the yield was 68%, and the purity was 99.5%.
Synthesis of Compound 13: 5.7 g (10.0 mmol) of Compound 12, 1.9 g of Compound 8 (1.2 eq., 12.0 mmol), 1.7 g of potassium carbonate (1.25 eq., 12.5 mmol) and 230 mg of Pd(PPh3)4 (0.02 eq., 0.2 mmol) were taken, and added into a three-necked flask. Vacuum pumping was performed, and nitrogen gas was introduced for replacement for many times. Then, 30 mL of dioxane and 10 mL of water were injected, and heating was performed to reach 100° C. After reaction for 12 hr under nitrogen gas protection, cooling was performed to reach the room temperature. Then, a proper amount of water and ethyl acetate were added for extraction, and an organic phase was collected. After drying by using anhydrous magnesium sulfate, rotary evaporation was performed to remove a solvent. A n-hexane/ethyl acetate system was used for column chromatography, to obtain 4.4 g of white solids, the yield was 85%, and the purity was 99.9%. Mass spectrum: (ESI−) ([M-H]−). C37H36N3 theoretical value: 522.30. Measured value: 522.31.
Synthesis of Compound P2: 1.04 g (2.0 mmol) of Compound 13, 160 mg of tetrabutylammonium bromide (0.25 eq., 0.5 mmol) and 930 mg of potassium chloroplatinate (1.2 eq., 2.4 mmol) were taken, and dissolved in 25 mL of acetic acid. Vacuum pumping was performed, and nitrogen gas was introduced for replacement for many times. Heating was performed under stirring to reach 130° C. for reaction for 12 Hr. After the reaction was completed, cooling and rotary evaporation were performed to remove a solvent. Then, a proper amount of water and ethyl acetate were added for extraction, and an organic phase was collected. After drying by using anhydrous magnesium sulfate, rotary evaporation was performed to remove a solvent. A n-hexane/ethyl acetate system was used for column chromatography. An obtained crude product was subjected to vacuum sublimation to obtain 716 mg of dark red solids, the total yield was 50%, and the purity was 99.9%. Mass spectrum: (ESI−) ([M-H]−). C37H35N3Pt theoretical value: 716.25. Measured value: 716.23.
Synthetic routes of P3 are basically identical to those of P1. Synthesis of partial compounds was shown as follows:
Synthesis of Compound 15: 18.9 g (40.0 mmol) of Compound 14, 34.0 g of Compound 4 (3 eq., 120.0 mmol), and 924 mg of Pd(PPh3)4 (0.02 eq., 0.8 mmol) were taken, and added into a three-necked flask. Vacuum pumping was performed, and nitrogen gas was introduced for replacement for many times. Then, 200 mL of toluene was injected, and heating was performed to reach 105° C. After reaction for 12 hr under nitrogen gas protection, cooling was performed to reach the room temperature. A KF solution was used for quenching reaction. Then, a proper amount of water and ethyl acetate were added for extraction, and an organic phase was collected. After drying by using anhydrous magnesium sulfate, rotary evaporation was performed to remove a solvent. A n-hexane/ethyl acetate system was used for column chromatography, to obtain 10.8 g of white solids, the yield was 80%, and the purity was 99.0%.
Synthesis of Compound 16: 10.3 g (20.0 mmol) of Compound 3, 6.8 g (20.0 mmol) of Compound 15, 3.4 g of potassium carbonate (1.25 eq., 25 mmol) and 462 mg of Pd(PPh3)4 (0.02 eq., 0.4 mmol) were taken, and added into a three-necked flask. Vacuum pumping was performed, and nitrogen gas was introduced for replacement for many times. Then, 60 mL of dioxane and 20 mL of water were injected, and heating was performed to reach 100° C. After reaction for 12 hr under nitrogen gas protection, cooling was performed to reach the room temperature. Then, a proper amount of water and ethyl acetate were added for extraction, and an organic phase was collected. After drying by using anhydrous magnesium sulfate, rotary evaporation was performed to remove a solvent. A n-hexane/ethyl acetate system was used for column chromatography, to obtain 7.9 g of white solids, the yield was 60%, and the purity was 99.5%.
Synthesis of Compound 17: 6.6 g (10.0 mmol) of Compound 16, 1.9 g of Compound 8 (1.2 eq., 12.0 mmol), 1.7 g of potassium carbonate (1.25 eq., 12.5 mmol) and 230 mg of Pd(PPh3)4 (0.02 eq., 0.2 mmol) were taken, and added into a three-necked flask. Vacuum pumping was performed, and nitrogen gas was introduced for replacement for many times. Then, 30 mL of dioxane and 10 mL of water were injected, and heating was performed to reach 100° C. After reaction for 12 hr under nitrogen gas protection, cooling was performed to reach the room temperature. Then, a proper amount of water and ethyl acetate were added for extraction, and an organic phase was collected. After drying by using anhydrous magnesium sulfate, rotary evaporation was performed to remove a solvent. A n-hexane/ethyl acetate system was used for column chromatography, to obtain 4.9 g of white solids, the yield was 80%, and the purity was 99.9%. Mass spectrum: (ESI−) ([M-H]−). C44H42N3 theoretical value: 612.35. Measured value: 612.33.
Synthesis of Compound P3: 1.23 g (2.0 mmol) of Compound 17, 160 mg of tetrabutylammonium bromide (0.25 eq., 0.5 mmol) and 930 mg of potassium chloroplatinate (1.2 eq., 2.4 mmol) were taken, and dissolved in 25 mL of acetic acid. Vacuum pumping was performed, and nitrogen gas was introduced for replacement for many times. Heating was performed under stirring to reach 130° C. for reaction for 12 Hr. After the reaction was completed, cooling and rotary evaporation were performed to remove a solvent. Then, a proper amount of water and ethyl acetate were added for extraction, and an organic phase was collected. After drying by using anhydrous magnesium sulfate, rotary evaporation was performed to remove a solvent. A n-hexane/ethyl acetate system was used for column chromatography. An obtained crude product was subjected to vacuum sublimation to obtain 887 mg of dark red solids, the total yield was 55%, and the purity was 99.9%. Mass spectrum: (ESI−) ([M-H]−). C44H41N3Pt theoretical value: 805.30. Measured value: 805.28.
Synthesis of Compound 19: 14.7 g (40.0 mmol) of Compound 5, 53.2 g of Compound 18 (3 eq., 120.0 mmol), and 924 mg of Pd(PPh3)4 (0.02 eq., 0.8 mmol) were taken, and added into a three-necked flask. Vacuum pumping was performed, and nitrogen gas was introduced for replacement for many times. Then, 200 mL of toluene was injected, and heating was performed to reach 105° C. After reaction for 12 hr under nitrogen gas protection, cooling was performed to reach the room temperature. A KF solution was used for quenching reaction. Then, a proper amount of water and ethyl acetate were added for extraction, and an organic phase was collected. After drying by using anhydrous magnesium sulfate, rotary evaporation was performed to remove a solvent. A n-hexane/ethyl acetate system was used for column chromatography, to obtain 13.4 g of white solids, the yield was 85%, and the purity was 99.0%.
Synthesis of Compound 20: 10.3 g (20.0 mmol) of Compound 3, 7.9 g (20.0 mmol) of Compound 19, 3.4 g of potassium carbonate (1.25 eq., 25 mmol) and 462 mg of Pd(PPh3)4 (0.02 eq., 0.4 mmol) were taken, and added into a three-necked flask. Vacuum pumping was performed, and nitrogen gas was introduced for replacement for many times. Then, 60 mL of dioxane and 20 mL of water were injected, and heating was performed to reach 100° C. After reaction for 12 hr under nitrogen gas protection, cooling was performed to reach the room temperature. Then, a proper amount of water and ethyl acetate were added for extraction, and an organic phase was collected. After drying by using anhydrous magnesium sulfate, rotary evaporation was performed to remove a solvent. A n-hexane/ethyl acetate system was used for column chromatography, to obtain 8.9 g of white solids, the yield was 62%, and the purity was 99.0%.
Synthesis of Compound 21: 7.2 g (10.0 mmol) of
Synthesis of Compound P4: 1.34 g (2.0 mmol) of Compound 21, 160 mg of tetrabutylammonium bromide (0.25 eq., 0.5 mmol) and 930 mg of potassium chloroplatinate (1.2 eq., 2.4 mmol) were taken, and dissolved in 25 mL of acetic acid. Vacuum pumping was performed, and nitrogen gas was introduced for replacement for many times. Heating was performed under stirring to reach 130° C. for reaction for 12 Hr. After the reaction was completed, cooling and rotary evaporation were performed to remove a solvent. Then, a proper amount of water and ethyl acetate were added for extraction, and an organic phase was collected. After drying by using anhydrous magnesium sulfate, rotary evaporation was performed to remove a solvent. A n-hexane/ethyl acetate system was used for column chromatography. An obtained crude product was subjected to vacuum sublimation to obtain 776 mg of dark red solids, the total yield was 45%, and the purity was 99.9%. Mass spectrum: (ESI−) ([M-H]−). C48H48N3Pt theoretical value: 861.36. Measured value: 861.33.
| P1 | |||
| | |||
| P2 | |||
| | |||
| P3 | |||
| | |||
| P4 | |||
| | |||
| Complex | Emission (dichloromethane solution) λmax/nm | ||
| P1 | 618 | ||
| P2 | 617 | ||
| P3 | 619 | ||
| P4 | 618 | ||
Application examples of the compound of the present invention are provided hereafter. ITO/TAPC (60 nm)/TCTA:Pt(II) (40 nm)/TmPyPb (30 nm)/LiF (1 nm)/Al (80 nm)
Preparation Mode of Device:
| Doping | Pt (II) | CE (cd/A) | PE (lm/W) | EQE (%) | |
| concentration | complex | Von (V) | at 1000 cd/A |
| 4 wt % | P0 | 3.4 | 69.4 | 60.5 | 14.0 |
| P1 | 3.1 | 72.6 | 64.8 | 16.2 | |
| P2 | 3.0 | 72.8 | 65.2 | 16.6 | |
| P3 | 3.0 | 73.5 | 67.6 | 17.5 | |
| P4 | 3.0 | 74.0 | 68.5 | 18.0 | |
| 8 wt % | P0 | 3.4 | 68.2 | 59.8 | 13.6 |
| P1 | 3.1 | 73.6 | 66.7 | 17.2 | |
| P2 | 3.0 | 74.8 | 67.0 | 17.5 | |
| P3 | 3.0 | 75.7 | 67.5 | 18.0 | |
| P4 | 3.0 | 77.0 | 68.6 | 19.2 | |
| 12 wt % | P0 | 3.4 | 66.8 | 58.2 | 13.0 |
| P1 | 3.1 | 74.6 | 67.5 | 17.8 | |
| P2 | 3.0 | 75.5 | 68.2 | 18.3 | |
| P3 | 3.0 | 76.5 | 69.2 | 18.6 | |
| P4 | 3.0 | 78.6 | 71.0 | 20.3 | |
Claims (7)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811626574.4 | 2018-12-28 | ||
| CN201811626574.4A CN111377970B (en) | 2018-12-28 | 2018-12-28 | Preparation and Application of a N`N`C`N Type Tetradentate Platinum(II) Complex |
| PCT/CN2019/115180 WO2020134568A1 (en) | 2018-12-28 | 2019-11-02 | Preparation of n^n^c^n tetradentate platinum (ii) complex and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| US20220112230A1 US20220112230A1 (en) | 2022-04-14 |
| US12122795B2 true US12122795B2 (en) | 2024-10-22 |
Family
ID=71128588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US17/297,998 Active 2041-04-18 US12122795B2 (en) | 2018-12-28 | 2019-11-02 | Preparation of N∧N∧C∧N tetradentate platinum (II) complex and uses thereof |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12122795B2 (en) |
| JP (1) | JP7249061B2 (en) |
| KR (1) | KR20210070342A (en) |
| CN (1) | CN111377970B (en) |
| DE (1) | DE112019005248T5 (en) |
| WO (1) | WO2020134568A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116969998A (en) * | 2022-04-19 | 2023-10-31 | 浙江工业大学 | Spiro chiral tetradentate metal platinum (II) and palladium (II) complex circularly polarized luminescent material based on carbazole coordination and application thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102666547A (en) | 2009-10-30 | 2012-09-12 | 住友化学株式会社 | Nitrogen-containing aromatic compounds and metal complexes |
| CN102898476A (en) | 2011-07-25 | 2013-01-30 | 通用显示公司 | Tetradentate platinum complexes |
| CN103102370A (en) | 2011-09-30 | 2013-05-15 | 通用显示公司 | Cyclometallated tetradentate Pt(II) complexes containing one or two imidazole rings with a twisted aryl bonded to N-1 |
| CN108276450A (en) | 2018-02-06 | 2018-07-13 | 南京工业大学 | Aryl-substituted tetradentate ligand coordinated platinum complex and synthesis method and application thereof |
| US20180248137A1 (en) | 2017-02-27 | 2018-08-30 | Samsung Electronics Co., Ltd. | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound |
| US20190103568A1 (en) * | 2017-09-29 | 2019-04-04 | Samsung Electronics Co., Ltd. | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110237578A1 (en) | 2008-09-18 | 2011-09-29 | Zhi-Liang Wei | Amide compounds, compositions and uses thereof |
| KR102501466B1 (en) * | 2017-04-21 | 2023-02-20 | 삼성전자주식회사 | Organometallic compound, organic light emitting device including the same and a composition for diagnosing including the same |
| KR102496480B1 (en) | 2017-04-25 | 2023-02-06 | 삼성전자주식회사 | Organometallic compound, organic light emitting device including the same and a composition including the same |
-
2018
- 2018-12-28 CN CN201811626574.4A patent/CN111377970B/en active Active
-
2019
- 2019-11-02 US US17/297,998 patent/US12122795B2/en active Active
- 2019-11-02 KR KR1020217013132A patent/KR20210070342A/en not_active Ceased
- 2019-11-02 DE DE112019005248.9T patent/DE112019005248T5/en active Pending
- 2019-11-02 WO PCT/CN2019/115180 patent/WO2020134568A1/en not_active Ceased
- 2019-11-02 JP JP2021529021A patent/JP7249061B2/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102666547A (en) | 2009-10-30 | 2012-09-12 | 住友化学株式会社 | Nitrogen-containing aromatic compounds and metal complexes |
| US20120270141A1 (en) * | 2009-10-30 | 2012-10-25 | Max Planck Gesellschaft Zur Foerderung Der Wissenschaften E.V. | Nitrogen-containing aromatic compounds and metal complexes |
| CN102898476A (en) | 2011-07-25 | 2013-01-30 | 通用显示公司 | Tetradentate platinum complexes |
| CN103102370A (en) | 2011-09-30 | 2013-05-15 | 通用显示公司 | Cyclometallated tetradentate Pt(II) complexes containing one or two imidazole rings with a twisted aryl bonded to N-1 |
| US20180248137A1 (en) | 2017-02-27 | 2018-08-30 | Samsung Electronics Co., Ltd. | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound |
| US20190103568A1 (en) * | 2017-09-29 | 2019-04-04 | Samsung Electronics Co., Ltd. | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound |
| CN108276450A (en) | 2018-02-06 | 2018-07-13 | 南京工业大学 | Aryl-substituted tetradentate ligand coordinated platinum complex and synthesis method and application thereof |
Non-Patent Citations (2)
| Title |
|---|
| Arnold, Lena, et al. "A porphyrin-related macrocycle from carbazole and pyridine building blocks: synthesis and metal coordination." Chemical Communications 47.3 (2011): 970-972. (Year: 2011). * |
| Corbet, Jean-Pierre, and Gerard Mignani. "Selected patented cross-coupling reaction technologies." Chemical reviews 106.7 (2006) : 2651-2710. (Year: 2006). * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20220112230A1 (en) | 2022-04-14 |
| JP2022511428A (en) | 2022-01-31 |
| JP7249061B2 (en) | 2023-03-30 |
| KR20210070342A (en) | 2021-06-14 |
| WO2020134568A1 (en) | 2020-07-02 |
| CN111377970B (en) | 2022-12-23 |
| CN111377970A (en) | 2020-07-07 |
| DE112019005248T5 (en) | 2021-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109980111B (en) | An organic electroluminescent device containing tetradentate platinum(II) complex | |
| CN109970714B (en) | Tetradentate platinum (II) complex and application thereof | |
| TWI774368B (en) | Preparation and application of a tetradentate platinum (ii) complex | |
| WO2019128895A1 (en) | Tetradentate platinum (ii) complex material based on oxazole, thiazole or imidazole and use | |
| US12464942B2 (en) | Preparation of N∧N∧C∧O tetradentate platinum (II) complex and uses thereof | |
| EP4545541B1 (en) | Circularly polarized light-emitting material and use, light-emitting display device, and display apparatus | |
| CN106831633A (en) | A kind of electroluminescent organic material and organic photoelectric device | |
| US10385059B2 (en) | Organic electroluminescent material and organic optoelectronic device | |
| US12122795B2 (en) | Preparation of N∧N∧C∧N tetradentate platinum (II) complex and uses thereof | |
| KR102699343B1 (en) | O^C^N^N type 4-membered platinum(II) compound, its preparation method and its application | |
| CN108586351A (en) | A kind of organic red light small molecule, preparation method and applications based on phenanthro- imidazoles-trans- diphenyl dicyanoethylene | |
| KR20110117513A (en) | Phosphorescent host material and organic light emitting device using the same | |
| CN113896735B (en) | Thermal-activation delayed red light material based on coumarin-pyrazine structure and application of thermal-activation delayed red light material in organic electroluminescent device | |
| JP7385754B2 (en) | Production and use of tetradentate platinum(II) complexes | |
| US11495711B2 (en) | Device comprising organometallic complex luminescent material | |
| CN109748936B (en) | An organometallic complex luminescent material |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
| AS | Assignment |
Owner name: GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD, CHINA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KANG, JIAN;DAI, LEI;CAI, LIFEI;REEL/FRAME:056416/0906 Effective date: 20210401 |
|
| FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
| ZAAB | Notice of allowance mailed |
Free format text: ORIGINAL CODE: MN/=. |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |


































